Regeneron Pharmaceuticals Inc (NAS:REGN)
$ 968 12.24 (1.28%) Market Cap: 106.66 Bil Enterprise Value: 98.84 Bil PE Ratio: 28.60 PB Ratio: 3.95 GF Score: 94/100

Regeneron Pharmaceuticals Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 10, 2021 / 01:00PM GMT
Release Date Price: $467.95 (-0.57%)
Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst

Okay. Great. Well, good morning. Welcome to day 2 of the Barclays Global Health Care Conference. I am Carter Gould, Senior Biopharma analyst here. I am pleased to welcome Regeneron to the next session kicking off day 2. Representing the company is Marion McCourt, she heads up the commercial effort. She's joined today by Justin Holko, who runs the IR squad.

Marion and Justin are going to make some opening comments, and then we'll jump into questions. Justin you are on mute.

Justin Holko
Regeneron Pharmaceuticals, Inc. - VP of IR

Well, thank you for that. Carter, thank you for the invitation. And before we begin, we'd like to remind you that remarks made on today's webcast do include forward-looking statements about Regeneron. Each forward-looking statement is subject to risks and uncertainties that could cause actual results and events to differ materially from those projected in the statement. More complete description of these and other material risks can be found in Regeneron

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot